Secretagogue pentapeptide

Ipamorelin

Ipamorelin is a pentapeptide investigated as a growth hormone secretagogue in pituitary-cell assays and animal models.

Quantity per vial

Select variantCompare prices and choose a variant to set the quantity and add it to your quote.

Subtotal excludes freight and taxes. Availability and final terms are confirmed in the quote. Commercial and shipping terms

Mechanism and findings

Mixed · Study formulation · Rat pituitary cells, rats and swine

GH secretagogue activity

Ipamorelin stimulated GH release in cellular and animal experiments; endocrine selectivity in swine is not proof of human safety.

Raun et al., 1998 →

Literature findings; refer to the model and formulation studied.

Mechanism of action

Ipamorelin — secretagogue pentapeptide. The literature identity must be matched to the documented chemical form and composition of the supplied material.

GHRP and GHRH antagonists were used to distinguish the GH-release pathway. Experiments indicated action through a GHRP-like receptor, with potency evaluated in pituitary cells and animals. Hormonal selectivity observed in swine belongs to that model.

  • GH secretagogue receptor

Raun et al., 1998

Studied findings 1
Mixed · Study formulation

GH secretagogue activity

Rat pituitary cells, rats and swine

Ipamorelin stimulated GH release in cellular and animal experiments; endocrine selectivity in swine is not proof of human safety.

View context
Study design
Original-study abstract; experimental design described in linked source
Sample scope / arm
Not extracted; consult original study
Comparator
See original-study context
Experimental context (not instructions for use)
Abstract-level extraction; full methods and tables still require review.
Source section / table / abstract
Abstract

Evidence concerns the studied material and model, not the supplied BLOPEP batch.

Raun et al., 1998

Sources and studies 2Peptide Monographs
  1. Ipamorelin — PubChem molecular identity

  2. Ipamorelin, the first selective growth hormone secretagogue.

    Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH · 1998 · European journal of endocrinology

    DOI: 10.1530/eje.0.1390552

Specifications and packaging

Nominal variant content; analytical results belong to the documented batch.

Material type
Peptide
Molecular formula (literature identity)
C38H49N9O5
Molecular weight (literature identity)
711.9 g/mol

Quality and analyses

Review specifications, analytical results and documentation for published batches.

Purity
>99%
Type
Declared specification

Published batches

Batch results have not yet been published on this page.

Storage

Consult the specific conditions in the supplied material documentation.

Delivery and commercial terms

Freight, timing and import terms will be confirmed in the quote for the selected destination.